Volatilomes of human infection.

Clinical Gas chromatography Mass spectrometry Metabolic pathways Microbial volatiles

Journal

Analytical and bioanalytical chemistry
ISSN: 1618-2650
Titre abrégé: Anal Bioanal Chem
Pays: Germany
ID NLM: 101134327

Informations de publication

Date de publication:
16 Oct 2023
Historique:
received: 31 07 2023
accepted: 03 10 2023
revised: 22 09 2023
medline: 16 10 2023
pubmed: 16 10 2023
entrez: 16 10 2023
Statut: aheadofprint

Résumé

The human volatilome comprises a vast mixture of volatile emissions produced by the human body and its microbiomes. Following infection, the human volatilome undergoes significant shifts, and presents a unique medium for non-invasive biomarker discovery. In this review, we examine how the onset of infection impacts the production of volatile metabolites that reflects dysbiosis by pathogenic microbes. We describe key analytical workflows applied across both microbial and clinical volatilomics and emphasize the value in linking microbial studies to clinical investigations to robustly elucidate the metabolic species and pathways leading to the observed volatile signatures. We review the current state of the art across microbial and clinical volatilomics, outlining common objectives and successes of microbial-clinical volatilomic workflows. Finally, we propose key challenges, as well as our perspectives on emerging opportunities for developing clinically useful and targeted workflows that could significantly enhance and expedite current practices in infection diagnosis and monitoring.

Identifiants

pubmed: 37843549
doi: 10.1007/s00216-023-04986-z
pii: 10.1007/s00216-023-04986-z
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Science Foundation Ireland
ID : SFI/12/RC/2289_P2
Pays : Ireland

Informations de copyright

© 2023. The Author(s).

Références

Shang Y, Li H, Zhang R. Effects of pandemic outbreak on economies: Evidence from business history context. Front Public Health. 2021;9:632043. https://doi.org/10.3389/fpubh.2021.632043 .
doi: 10.3389/fpubh.2021.632043 pubmed: 33777885 pmcid: 7994505
Verikios G. The dynamic effects of infectious disease outbreaks: The case of pandemic influenza and human coronavirus. Socioecon Plann Sci. 2020;71:100898. https://doi.org/10.1016/j.seps.2020.100898 .
doi: 10.1016/j.seps.2020.100898 pubmed: 32834133 pmcid: 7286241
Brancalion PHS, Broadbent EN, de- Miguel S, Cardil A, Rosa MR, Almeida CT, DRA A, Chakravarty S, Zhou M, JGP G, Liang J, Crouzeilles R, Hérault B, LEOC A, Silva CA, Almeyda-Zambrano AM. Emerging threats linking tropical deforestation and the COVID-19 pandemic. Perspect Ecol Conserv. 2020;18:243–6. https://doi.org/10.1016/j.pecon.2020.09.006 .
doi: 10.1016/j.pecon.2020.09.006 pubmed: 33020748 pmcid: 7526655
Wolfe ND, Daszak P, Kilpatrick AM, Burke DS. Bushmeat hunting, deforestation, and prediction of zoonotic disease. Emerg Infect Dis. 2005;11:1822–7. https://doi.org/10.3201/eid1112.040789 .
doi: 10.3201/eid1112.040789 pubmed: 16485465 pmcid: 3367616
Chen J, Ying G-G, Deng W-J. Antibiotic residues in food: extraction, analysis, and human health concerns. J Agric Food Chem. 2019;67:7569–86. https://doi.org/10.1021/acs.jafc.9b01334 .
doi: 10.1021/acs.jafc.9b01334 pubmed: 31198037
Frieri M, Kumar K, Boutin A. Antibiotic resistance. J Infect. Public Health. 2017;10:369–78. https://doi.org/10.1016/j.jiph.2016.08.007 .
doi: 10.1016/j.jiph.2016.08.007
Lipsky BA, Senneville É, Abbas ZG, Aragón-Sánchez J, Diggle M, Embil JM, Kono S, Lavery LA, Malone M, van Asten SA, Urbančič-Rovan V, EJG P, International Working Group on the Diabetic Foot. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes. Diabetes Metab Res Rev. 2020;36:e3280. https://doi.org/10.1002/dmrr.3280 .
doi: 10.1002/dmrr.3280 pubmed: 32176444
Park JH, Suh DH, Kim HJ, Lee YI, Kwak IH, Choi GW. Role of procalcitonin in infected diabetic foot ulcer. Diabetes Res Clin Pract. 2017;128:51–7. https://doi.org/10.1016/j.diabres.2017.04.008 .
doi: 10.1016/j.diabres.2017.04.008 pubmed: 28448892
Weisskopf L, Schulz S, Garbeva P. Microbial volatile organic compounds in intra-kingdom and inter-kingdom interactions. Nat Rev Microbiol. 2021;19:391–404. https://doi.org/10.1038/s41579-020-00508-1 .
doi: 10.1038/s41579-020-00508-1 pubmed: 33526910
Choong-Min R, Weisskopf L, Piechulla B. Bacterial volatile compounds as mediators of airborne interactions. 1st ed. Springer, Singapore; 2020.
Elmassry MM, Piechulla B. Volatilomes of bacterial infections in humans. Front Neurosci. 2020;14:257. https://doi.org/10.3389/fnins.2020.00257 .
doi: 10.3389/fnins.2020.00257 pubmed: 32269511 pmcid: 7111428
Schulz S, Dickschat JS. Bacterial volatiles: the smell of small organisms. Nat Prod Rep. 2007;24:814–42. https://doi.org/10.1039/B507392H .
doi: 10.1039/B507392H pubmed: 17653361
Kai M. Diversity and distribution of volatile secondary metabolites throughout bacillus subtilis isolates. Front Microbiol. 2020;11:559. https://doi.org/10.3389/fmicb.2020.00559 .
doi: 10.3389/fmicb.2020.00559 pubmed: 32322244 pmcid: 7156558
Lemfack MC, Gohlke B-O, Toguem SMT, Preissner S, Piechulla B, Preissner R. mVOC 2.0: a database of microbial volatiles. Nucleic Acids Res. 2018;46:D1261–5. https://doi.org/10.1093/nar/gkx1016 .
doi: 10.1093/nar/gkx1016 pubmed: 29106611
Pott DM, Osorio S, Vallarino JG. From central to specialized metabolism: An overview of some secondary compounds derived from the primary metabolism for their role in conferring nutritional and organoleptic characteristics to fruit. Front Plant Sci. 2019;10:835. https://doi.org/10.3389/fpls.2019.00835 .
doi: 10.3389/fpls.2019.00835 pubmed: 31316537 pmcid: 6609884
Kracke F, Vassilev I, Krömer JO. Microbial electron transport and energy conservation – the foundation for optimizing bioelectrochemical systems. Front Microbiol. 2015;6:575. https://doi.org/10.3389/fmicb.2015.00575 .
doi: 10.3389/fmicb.2015.00575 pubmed: 26124754 pmcid: 4463002
Basan M, Hui S, Okano H, Zhang Z, Shen Y, Williamson JR, Hwa T. Overflow metabolism in Escherichia coli results from efficient proteome allocation. Nature. 2015;528:99–104. https://doi.org/10.1038/nature15765 .
doi: 10.1038/nature15765 pubmed: 26632588 pmcid: 4843128
Wolfe AJ. The acetate switch. Microbiol Mol Biol Rev. 2005;69:12–50. https://doi.org/10.1128/MMBR.69.1.12-50.2005 .
doi: 10.1128/MMBR.69.1.12-50.2005 pubmed: 15755952 pmcid: 1082793
Pfeiffer T, Morley A. An evolutionary perspective on the Crabtree effect. Front Mol Biosci. 2014;1:17. https://doi.org/10.3389/fmolb.2014.00017 .
doi: 10.3389/fmolb.2014.00017 pubmed: 25988158 pmcid: 4429655
Gottschalk G. Bacterial metabolism. 2nd ed. New York, NY: Springer; 1986.
doi: 10.1007/978-1-4612-1072-6
Díaz-Pérez AL, Díaz-Pérez C, Campos-García J. Bacterial l-leucine catabolism as a source of secondary metabolites. Rev Environ Sci Biotechnol. 2016;15:1–29. https://doi.org/10.1007/s11157-015-9385-3 .
doi: 10.1007/s11157-015-9385-3
Herrmann KM, Weaver LM. The Shikimate pathway. Annu Rev Plant Physiol Plant Mol Biol. 1999;50:473–503. https://doi.org/10.1146/annurev.arplant.50.1.473 .
doi: 10.1146/annurev.arplant.50.1.473 pubmed: 15012217
Zhang H, Cao M, Jiang X, Zou H, Wang C, Xu X, Xian M. De-novo synthesis of 2-phenylethanol by Enterobactersp. CGMCC 5087. BMC Biotechnol. 2014;14:30. https://doi.org/10.1186/1472-6750-14-30 .
doi: 10.1186/1472-6750-14-30 pubmed: 24766677 pmcid: 4005845
Roager HM, Licht TR. Microbial tryptophan catabolites in health and disease. Nat Commun. 2018;9:3294. https://doi.org/10.1038/s41467-018-05470-4 .
doi: 10.1038/s41467-018-05470-4 pubmed: 30120222 pmcid: 6098093
Mann S. Chinazolinderivate bei Pseudomonaden. Arch Für Mikrobiol. 1967;56:324–9. https://doi.org/10.1007/BF00425207 .
doi: 10.1007/BF00425207
Zhu Z, Wang H, Shang Q, Jiang Y, Cao Y, Chai Y. Time course analysis of candida albicans metabolites during biofilm development. J Proteome Res. 2013;12:2375–85. https://doi.org/10.1021/pr300447k .
doi: 10.1021/pr300447k pubmed: 22834926
Fitzgerald S, Furlong C, Holland L, Morrin A. Multi-strain and -species investigation of volatile metabolites emitted from planktonic and biofilm candida cultures. Metabolites. 2022;12:432. https://doi.org/10.3390/metabo12050432 .
doi: 10.3390/metabo12050432 pubmed: 35629935 pmcid: 9146923
Brock NL, Menke M, Klapschinski TA, Dickschat JS. Marine bacteria from the Roseobacter clade produce sulfur volatiles via amino acid and dimethylsulfoniopropionate catabolism. Org Biomol Chem. 2014;12:4318–23. https://doi.org/10.1039/C4OB00719K .
doi: 10.1039/C4OB00719K pubmed: 24848489
Schäfer H, Eyice Ö. Microbial cycling of methanethiol. Curr Issues Mol Biol. 2019;33:173–82. https://doi.org/10.21775/cimb.033.173 .
doi: 10.21775/cimb.033.173 pubmed: 31166191
Landaud S, Helinck S, Bonnarme P. Formation of volatile sulfur compounds and metabolism of methionine and other sulfur compounds in fermented food. Appl Microbiol Biotechnol. 2008;77:1191–205. https://doi.org/10.1007/s00253-007-1288-y .
doi: 10.1007/s00253-007-1288-y pubmed: 18064452
Lee H, Kho H-S, Chung J-W, Chung S-C, Kim Y-K. Volatile sulfur compounds produced by Helicobacter pylori. J Clin Gastroenterol. 2006;40:421. https://doi.org/10.5009/gnl.2008.2.2.113 .
doi: 10.5009/gnl.2008.2.2.113 pubmed: 16721224
Rees CA, Shen A, Hill JE. Characterization of the Clostridium difficile volatile metabolome using comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry. J Chromatogr B. 2016;1039:8–16. https://doi.org/10.1016/j.jchromb.2016.11.009 .
doi: 10.1016/j.jchromb.2016.11.009
Pandey A, Sassetti C. Mycobacterial persistence requires the utilization of host cholesterol. Proc Natl Acad Sci. 2008;105:4376–80.
doi: 10.1073/pnas.0711159105 pubmed: 18334639 pmcid: 2393810
van der Meer-Janssen YPM, van Galen J, Batenburg JJ, Helms JB. Lipids in host–pathogen interactions: Pathogens exploit the complexity of the host cell lipidome. Prog Lipid Res. 2010;49:1–26. https://doi.org/10.1016/j.plipres.2009.07.003 .
doi: 10.1016/j.plipres.2009.07.003 pubmed: 19638285
Fujita Y, Matsuoka H, Hirooka K. Regulation of fatty acid metabolism in bacteria. Mol Microbiol. 2007;66:829–39. https://doi.org/10.1111/j.1365-2958.2007.05947.x .
doi: 10.1111/j.1365-2958.2007.05947.x pubmed: 17919287
Gao J, Zou Y, Wang Y, Wang F, Lang L, Wang P, Zhou Y, Ying K. Breath analysis for noninvasively differentiating Acinetobacter baumannii ventilator-associated pneumonia from its respiratory tract colonization of ventilated patients. J Breath Res. 2016;10:027102. https://doi.org/10.1088/1752-7155/10/2/027102 .
doi: 10.1088/1752-7155/10/2/027102 pubmed: 27272697
Filipiak W, Beer W, Sponring A, Filipiak A, Ager C, Schiefecker A, Lanthaler S, Helbok R, Nagl M, Troppmair J, Amann A. Breath analysis for in vivo detection of pathogens related to ventilator-associated pneumonia in intensive care patients: a prospective pilot study. J Breath Res. 2015;9:016004. https://doi.org/10.1088/1752-7155/9/1/016004 .
doi: 10.1088/1752-7155/9/1/016004 pubmed: 25557917
Jenkins CL, Bean HD. Dependence of the Staphylococcal volatilome composition on microbial nutrition. Metabolites. 2020;10:347. https://doi.org/10.3390/metabo10090347 .
doi: 10.3390/metabo10090347 pubmed: 32867100 pmcid: 7569959
Mellors TR, Nasir M, Franchina FA, Smolinska A, Blanchet L, Flynn JL, Tomko J, O’Malley M, Scanga CA, Lin PL, Wagner J, Hill JE. Identification of Mycobacterium tuberculosis using volatile biomarkers in culture and exhaled breath. J Breath Res. 2018;13:016004. https://doi.org/10.1088/1752-7163/aacd18 .
doi: 10.1088/1752-7163/aacd18 pubmed: 29910196
Fitzgerald S, Holland L, Morrin A. An investigation of stability and species and strain-level specificity in bacterial volatilomes. Front Microbiol. 2021;12
Fitzgerald S, Duffy E, Holland L, Morrin A. Multi-strain volatile profiling of pathogenic and commensal cutaneous bacteria. Sci Rep. 2020;10:17971. https://doi.org/10.1038/s41598-020-74909-w .
doi: 10.1038/s41598-020-74909-w pubmed: 33087843 pmcid: 7578783
Ahmed W, Bardin E, Davis MD, Sermet-Gaudelus I, Grassin Delyle S, Fowler SJ. Volatile metabolites differentiate air–liquid interface cultures after infection with Staphylococcus aureus. The Analyst. 2023;148:618–27. https://doi.org/10.1039/D2AN01205G .
doi: 10.1039/D2AN01205G pubmed: 36597770
Ahmed WM, Lawal O, Nijsen TM, Goodacre R, Fowler SJ. Exhaled volatile organic compounds of infection: A systematic review. ACS Infect Dis. 2017;3:695–710. https://doi.org/10.1021/acsinfecdis.7b00088 .
doi: 10.1021/acsinfecdis.7b00088 pubmed: 28870074
Lawal O, Ahmed WM, Nijsen TME, Goodacre R, Fowler SJ. Exhaled breath analysis: a review of “breath-taking” methods for off-line analysis. Metabolomics Off J Metabolomic Soc. 2017;13:110. https://doi.org/10.1007/s11306-017-1241-8 .
doi: 10.1007/s11306-017-1241-8
Lawson J, Beauchamp J. Pursuing breath research in unprecedented circumstances-report from the Breath Biopsy Conference 2020. J Breath Res. 2021;15:030201. https://doi.org/10.1088/1752-7163/ac09d3 .
doi: 10.1088/1752-7163/ac09d3
Beccaria M, Bobak C, Maitshotlo B, Mellors TR, Purcaro G, Franchina FA, Rees CA, Nasir M, Black A, Hill JE. Exhaled human breath analysis in active pulmonary tuberculosis diagnostics by comprehensive gas chromatography-mass spectrometry and chemometric techniques. J Breath Res. 2018;13:016005. https://doi.org/10.1088/1752-7163/aae80e .
doi: 10.1088/1752-7163/aae80e pubmed: 30394364 pmcid: 6537098
Shestivska V, Dryahina K, Nunvář J, Sovová K, Elhottová D, Nemec A, Smith D, Španěl P. Quantitative analysis of volatile metabolites released in vitro by bacteria of the genus Stenotrophomonas for identification of breath biomarkers of respiratory infection in cystic fibrosis. J Breath Res. 2015;9:027104. https://doi.org/10.1088/1752-7155/9/2/027104 .
doi: 10.1088/1752-7155/9/2/027104 pubmed: 25830686
Ebadzadsahrai G, Higgins Keppler EA, Soby SD, Bean HD. Inhibition of fungal growth and induction of a novel volatilome in response to Chromobacterium vaccinii volatile organic compounds. Front Microbiol. 2020;11:1035. https://doi.org/10.3389/fmicb.2020.01035 .
doi: 10.3389/fmicb.2020.01035 pubmed: 32508802 pmcid: 7251293
Huubschmann H-J. Handbook of GC-MS: Fundamentals and applications. 3rd ed. Wiley; 2015.
doi: 10.1002/9783527674305
Franchina FA, Zanella D, Dejong T, Focant J-F. Impact of the adsorbent material on volatile metabolites during in vitro and in vivo bio-sampling. Talanta. 2021;222:121569. https://doi.org/10.1016/j.talanta.2020.121569 .
doi: 10.1016/j.talanta.2020.121569 pubmed: 33167263
Pawliszyn J. Handbook of solid phase microextraction. 1st ed. Elsevier; 2011.
Pena-Pereira F, Romero V, de la Calle I, Lavilla I, Bendicho C. Graphene-based nanocomposites in analytical extraction processes. TrAC Trends Anal Chem. 2021;142:116303. https://doi.org/10.1016/j.trac.2021.116303 .
doi: 10.1016/j.trac.2021.116303
Ratiu I-A, Bocos-Bintintan V, Monedeiro F, Milanowski M, Ligor T, Buszewski B. An optimistic vision of future: Diagnosis of bacterial infections by sensing their associated volatile organic compounds. Crit Rev Anal Chem. 2020;50:501–12. https://doi.org/10.1080/10408347.2019.1663147 .
doi: 10.1080/10408347.2019.1663147 pubmed: 31514505
Ruszkiewicz DM, Sanders D, O’Brien R, Hempel F, Reed MJ, Riepe AC, Bailie K, Brodrick E, Darnley K, Ellerkmann R, Mueller O, Skarysz A, Truss M, Wortelmann T, Yordanov S, Thomas CLP, Schaaf B, Eddleston M. Diagnosis of COVID-19 by analysis of breath with gas chromatography-ion mobility spectrometry - a feasibility study. EClinicalMedicine. 2020;29:100609. https://doi.org/10.1016/j.eclinm.2020.100609 .
doi: 10.1016/j.eclinm.2020.100609 pubmed: 33134902
Belluomo I, Boshier PR, Myridakis A, Vadhwana B, Markar SR, Spanel P, Hanna GB. Selected ion flow tube mass spectrometry for targeted analysis of volatile organic compounds in human breath. Nat Protoc. 2021;16:3419–38. https://doi.org/10.1038/s41596-021-00542-0 .
doi: 10.1038/s41596-021-00542-0 pubmed: 34089020
Pleil JD, Hansel A, Beauchamp J. Advances in proton transfer reaction mass spectrometry (PTR-MS): applications in exhaled breath analysis, food science, and atmospheric chemistry. J Breath Res. 2019;13:039002. https://doi.org/10.1088/1752-7163/ab21a7 .
doi: 10.1088/1752-7163/ab21a7 pubmed: 31085815 pmcid: 8188715
Dummer J, Storer M, Sturney S, Scott-Thomas A, Chambers S, Swanney M, Epton M. Quantification of hydrogen cyanide (HCN) in breath using selected ion flow tube mass spectrometry—HCN is not a biomarker of Pseudomonas in chronic suppurative lung disease. J Breath Res. 2013;7:017105. https://doi.org/10.1088/1752-7155/7/1/017105 .
doi: 10.1088/1752-7155/7/1/017105 pubmed: 23445778
King J, Mochalski P, Kupferthaler A, Unterkofler K, Koc H, Filipiak W, Teschl S, Hinterhuber H, Amann A. Dynamic profiles of volatile organic compounds in exhaled breath as determined by a coupled PTR-MS/GC-MS study. Physiol Meas. 2010;31:1169–84. https://doi.org/10.1088/0967-3334/31/9/008 .
doi: 10.1088/0967-3334/31/9/008 pubmed: 20664160
Nikolic MV, Milovanovic V, Vasiljevic ZZ, Stamenkovic Z. Semiconductor gas sensors: Materials, technology, design, and application. Sensors. 2020;20:6694. https://doi.org/10.3390/s20226694 .
doi: 10.3390/s20226694 pubmed: 33238459 pmcid: 7700484
Dragonieri S, Pennazza G, Carratu P, Resta O. Electronic nose technology in respiratory diseases. Lung. 2017;195:157–65. https://doi.org/10.1007/s00408-017-9987-3 .
doi: 10.1007/s00408-017-9987-3 pubmed: 28238110
Chen J, Tang J, Shi H, Tang C, Zhang R. Characteristics of volatile organic compounds produced from five pathogenic bacteria by headspace-solid phase micro-extraction/gas chromatography-mass spectrometry. J Basic Microbiol. 2017;57:228–37. https://doi.org/10.1002/jobm.201600505 .
doi: 10.1002/jobm.201600505 pubmed: 27874211
Duffy E, Jacobs MR, Kirby B, Morrin A. Probing skin physiology through the volatile footprint: discriminating volatile emissions before and after acute barrier disruption. Exp Dermatol. 2017;26:919–25. https://doi.org/10.1111/exd.13344 .
doi: 10.1111/exd.13344 pubmed: 28370710
Yuan Z-C, Zhang Y, Cai S-H, Chen W, Hu B. Solid phase microextraction for human breath analysis of environmental and occupational exposures: A review. Adv Sample Prep. 2022;3:100023. https://doi.org/10.1016/j.sampre.2022.100023 .
doi: 10.1016/j.sampre.2022.100023
Yuan Z-C, Li W, Wu L, Huang D, Wu M, Hu B. Solid-phase microextraction fiber in face mask for in vivo sampling and direct mass spectrometry analysis of exhaled breath aerosol. Anal Chem. 2020;92:11543–7. https://doi.org/10.1021/acs.analchem.0c02118 .
doi: 10.1021/acs.analchem.0c02118 pubmed: 32786499
Zhu J, Chaudhury M, Durso L, Sagel A, Skoda S, Jelvez-Serra N, Santanab E. Semiochemicals released from five bacteria identified from animal wounds infested by primary screwworms and their effects on fly behavioral activity. PLOS ONE. 2017;12:0179090. https://doi.org/10.1371/journal.pone.0179090 .
doi: 10.1371/journal.pone.0179090
Shirasu M, Nagai S, Hayashi R, Ochiai A, Touhara K. Dimethyl trisulfide as a characteristic odor associated with fungating cancer wounds. Biosci Biotechnol Biochem. 2009;73:2117–20. https://doi.org/10.1271/bbb.90229 .
doi: 10.1271/bbb.90229 pubmed: 19734656
Thuleau A, Dugay J, Dancremont C, Jemmali Z, Elard J, Ricke Y, Cassoux N, Watson S, Escande M, Fromantin I. Volatile organic compounds of malignant breast cancer wounds: Identification and odors. Wounds. 2018;30:337–44.
pubmed: 30380523
Bond A, Vernon A, Reade S, Mayor A, Minetti C, Wastling J, Lamden K, Probert C. Investigation of volatile organic compounds emitted from faeces for the diagnosis of Giardiasis. J Gastrointestin Liver Dis. 2015;24:281–6. https://doi.org/10.15403/jgld.2014.1121.243.abo .
doi: 10.15403/jgld.2014.1121.243.abo pubmed: 26405699
Oertel P, Bergmann A, Fischer S, Trefz P, Küntzel A, Reinhold P, Köhler H, Schubert JK, Miekisch W. Evaluation of needle trap micro-extraction and solid-phase micro-extraction: Obtaining comprehensive information on volatile emissions from in vitro cultures. Biomed Chromatogr BMC. 2018;32:e4285. https://doi.org/10.1002/bmc.4285 .
doi: 10.1002/bmc.4285 pubmed: 29761519
Filipiak W, Żuchowska K, Marszałek M, Depka D, Bogiel T, Warmuzińska N, Bojko B. GC-MS profiling of volatile metabolites produced by Klebsiella pneumoniae. Front Mol Biosci. 2022;9:1019290. https://doi.org/10.3389/fmolb.2022.1019290 .
doi: 10.3389/fmolb.2022.1019290 pubmed: 36330222 pmcid: 9623108
Elgaali H, Hamilton-Kemp T, Newman M, Collins R, Yu K, Archbold D. Comparison of long-chain alcohols and other volatile compounds emitted from food-borne and related Gram positive and Gram negative bacteria. J Basic Microbiol. 2002;42:373–80. https://doi.org/10.1002/1521-4028(200212)42:6<373::AID-JOBM373>3.0.CO;2-4 .
doi: 10.1002/1521-4028(200212)42:6<373::AID-JOBM373>3.0.CO;2-4 pubmed: 12442299
Romano A, Doran S, Belluomo I, Hanna GB. High-throughput breath volatile organic compound analysis using thermal desorption proton transfer reaction time-of-flight mass spectrometry. Anal Chem. 2018;90:10204–10. https://doi.org/10.1021/acs.analchem.8b01045 .
doi: 10.1021/acs.analchem.8b01045 pubmed: 30106567
Patel M, Fowler D, Sizer J, Walton C. Faecal volatile biomarkers of Clostridium difficile infection. PLOS ONE. 2019;14:e0215256. https://doi.org/10.1371/journal.pone.0215256 .
doi: 10.1371/journal.pone.0215256 pubmed: 30986230 pmcid: 6464219
Ashrafi M, Novak-Frazer L, Bates M, Baguneid M, Alonso-Rasgado T, Xia G, Rautemaa-Richardson R, Bayat A. Validation of biofilm formation on human skin wound models and demonstration of clinically translatable bacteria-specific volatile signatures. Sci Rep. 2018;8:9431. https://doi.org/10.1038/s41598-018-27504-z .
doi: 10.1038/s41598-018-27504-z pubmed: 29930327 pmcid: 6013498
Ashrafi M, Bates M, Baguneid M, Alonso-Rasgado T, Rautemaa-Richardson R, Bayat A. Volatile organic compound detection as a potential means of diagnosing cutaneous wound infections. Wound Repair Regen. 2017;25:574–90. https://doi.org/10.1111/wrr.12563 .
doi: 10.1111/wrr.12563 pubmed: 28727229
Traxler S, Bischoff A-C, Saß R, Trefz P, Gierschner P, Brock B, Schwaiger T, Karte C, Blohm U, Schröder C, Miekisch W, Schubert JK. VOC breath profile in spontaneously breathing awake swine during Influenza A infection. Sci Rep. 2018;8:14857. https://doi.org/10.1038/s41598-018-33061-2 .
doi: 10.1038/s41598-018-33061-2 pubmed: 30291257 pmcid: 6173698
Shestivska V, Nemec A, Dřevínek P, Sovová K, Dryahina K, Španěl P. Quantification of methyl thiocyanate in the headspace of Pseudomonas aeruginosa cultures and in the breath of cystic fibrosis patients by selected ion flow tube mass spectrometry. Rapid Commun Mass Spectrom. 2011;25:2459–67. https://doi.org/10.1002/rcm.5146 .
doi: 10.1002/rcm.5146 pubmed: 21818806
Shestivska V, Španěl P, Dryahina K, Sovová K, Smith D, Musílek M, Nemec A. Variability in the concentrations of volatile metabolites emitted by genotypically different strains of Pseudomonas aeruginosa. J Appl Microbiol. 2012;113:701–13. https://doi.org/10.1111/j.1365-2672.2012.05370.x .
doi: 10.1111/j.1365-2672.2012.05370.x pubmed: 22726261
Bunge M, Araghipour N, Mikoviny T, Dunkl J, Schnitzhofer R, Hansel A, Schinner F, Wisthaler A, Margesin R, Mark T. On-Line monitoring of microbial volatile metabolites by proton transfer reaction-mass spectrometry. Appl Env Microbiol. 2008;74:2179–86. https://doi.org/10.1128/AEM.02069-07 .
doi: 10.1128/AEM.02069-07
Slade E, Thorn R, Young A, Reynolds D. Real-time detection of volatile metabolites enabling species-level discrimination of bacterial biofilms associated with wound infection. J Appl Microbiol. 2021;132:1558–72. https://doi.org/10.1111/jam.15313 .
doi: 10.1111/jam.15313 pubmed: 34617369 pmcid: 9298000
Zhu J, Bean H, Kuo Y, Hill J. Fast detection of volatile organic compounds from bacterial cultures by secondary electrospray ionization-mass spectrometry. J Clin Microbiol. 2011;49:769–9. https://doi.org/10.1128/JCM.00392-10 .
doi: 10.1128/JCM.00392-10 pmcid: 3043467
Martínez-Lozano P, de la Mora JF. On-line detection of human skin vapors. J Am Soc Mass Spectrom. 2009;20:1060–3. https://doi.org/10.1016/j.jasms.2009.01.012 .
doi: 10.1016/j.jasms.2009.01.012 pubmed: 19251441
Kumar S, Huang J, Abbassi-Ghadi N, Španěl P, Smith D, Hanna GB. Selected ion flow tube mass spectrometry analysis of exhaled breath for volatile organic compound profiling of esophago-gastric cancer. Anal Chem. 2013;85:6121–8. https://doi.org/10.1021/ac4010309 .
doi: 10.1021/ac4010309 pubmed: 23659180
Adam ME, Fehervari M, Boshier PR, Chin S-T, Lin G-P, Romano A, Kumar S, Hanna GB. Mass-spectrometry analysis of mixed-breath, isolated-bronchial-breath, and gastric-endoluminal-air volatile fatty acids in esophagogastric cancer. Anal Chem. 2019;91:3740–6. https://doi.org/10.1021/acs.analchem.9b00148 .
doi: 10.1021/acs.analchem.9b00148 pubmed: 30699297
Grassin-Delyle S, Roquencourt C, Moine P, Saffroy G, Carn S, Heming N, Fleuriet J, Salvator H, Naline E, Couderc L-J, Devillier P, Thévenot EA, Annane D. Metabolomics of exhaled breath in critically ill COVID-19 patients: A pilot study. EBioMedicine. 2021;63:103154. https://doi.org/10.1016/j.ebiom.2020.103154 .
doi: 10.1016/j.ebiom.2020.103154 pubmed: 33279860
Lemfack MC, Nickel J, Dunkel M, Preissner R, Piechulla B. mVOC: a database of microbial volatiles. Nucleic Acids Res. 2014;42:744–8. https://doi.org/10.1093/nar/gkt1250 .
doi: 10.1093/nar/gkt1250
Bean HD, Rees CA, Hill JE. Comparative analysis of the volatile metabolomes of Pseudomonas aeruginosa clinical isolates. J Breath Res. 2016;10:047102. https://doi.org/10.1088/1752-7155/10/4/047102 .
doi: 10.1088/1752-7155/10/4/047102 pubmed: 27869104 pmcid: 5266606
Kai M, Effmert U, Lemfack MC, Piechulla B. Interspecific formation of the antimicrobial volatile schleiferon. Sci Rep. 2018;8:16852. https://doi.org/10.1038/s41598-018-35341-3 .
doi: 10.1038/s41598-018-35341-3 pubmed: 30442919 pmcid: 6237861
Misztal PK, Lymperopoulou DS, Adams RI, Scott RA, Lindow SE, Bruns T, Taylor JW, Uehling J, Bonito G, Vilgalys R, Goldstein AH. Emission factors of microbial volatile organic compounds from environmental bacteria and fungi. Environ Sci Technol. 2018;52:8272–82. https://doi.org/10.1021/acs.est.8b00806 .
doi: 10.1021/acs.est.8b00806 pubmed: 29947506
Ahmed WM, Fenn D, White IR, Dixon B, TME N, Knobel HH, Brinkman P, PMP VO, Schultz MJ, Dark P, Goodacre R, Felton T, LDJ B, Fowler SJ, for the BreathDx Consortium. Microbial volatiles as diagnostic biomarkers of bacterial lung infection in mechanically ventilated patients. Clin Infect Dis. 2022;76:1059–66. https://doi.org/10.1093/cid/ciac859 .
doi: 10.1093/cid/ciac859 pmcid: 10029988
Rees CA, Nordick KV, Franchina FA, Lewis AE, Hirsch EB, Hill JE. Volatile metabolic diversity of Klebsiella pneumoniae in nutrient-replete conditions. Metabolomics. 2017;13:18. https://doi.org/10.1007/s11306-016-1161-z .
doi: 10.1007/s11306-016-1161-z pubmed: 30464740 pmcid: 6241307
Kamal F, Kumar S, Edwards MR, Veselkov K, Belluomo I, Kebadze T, Romano A, Trujillo-Torralbo M-B, Shahridan Faiez T, Walton R, Ritchie AI, Wiseman DJ, Laponogov I, Donaldson G, Wedzicha JA, Johnston SL, Singanayagam A, Hanna GB. Virus-induced volatile organic compounds are detectable in exhaled breath during pulmonary infection. Am J Respir Crit Care Med. 2021;204:1075–85. https://doi.org/10.1164/rccm.202103-0660OC .
doi: 10.1164/rccm.202103-0660OC pubmed: 34319857 pmcid: 8663017
Purcaro G, Rees CA, Wieland-Alter WF, Schneider MJ, Wang X, Stefanuto P-H, Wright PF, Enelow RI, Hill JE. Volatile fingerprinting of human respiratory viruses from cell culture. J Breath Res. 2018;12:026015. https://doi.org/10.1088/1752-7163/aa9eef .
doi: 10.1088/1752-7163/aa9eef pubmed: 29199638 pmcid: 5912890
Sanchez EL, Lagunoff M. Viral activation of cellular metabolism. Virology. 2015;479–480:609–18. https://doi.org/10.1016/j.virol.2015.02.038 .
doi: 10.1016/j.virol.2015.02.038 pubmed: 25812764
Schnabel R, Fijten R, Smolinska A, Dallinga J, Boumans M-L, Stobberingh E, Boots A, Roekaerts P, Bergmans D, van Schooten FJ. Analysis of volatile organic compounds in exhaled breath to diagnose ventilator-associated pneumonia. Sci Rep. 2015;5:17179. https://doi.org/10.1038/srep17179 .
doi: 10.1038/srep17179 pubmed: 26608483 pmcid: 4660425
Fowler SJ, Basanta-Sanchez M, Xu Y, Goodacre R, Dark PM. Surveillance for lower airway pathogens in mechanically ventilated patients by metabolomic analysis of exhaled breath: a case-control study. Thorax. 2015;70:320–5. https://doi.org/10.1136/thoraxjnl-2014-206273 .
doi: 10.1136/thoraxjnl-2014-206273 pubmed: 25661115
van Oort PM, Nijsen TM, White IR, Knobel HH, Felton T, Rattray N, Lawal O, Bulut M, Ahmed W, Artigas A, Povoa PR, Martin-Loeches I, Weda H, Goodacre R, Schultz MJ, Dark PM, Fowler SJ, Bos LD. Untargeted molecular analysis of exhaled breath as a diagnostic test for ventilator-associated lower respiratory tract infections (BreathDx). Thorax. 2022;77:79–81. https://doi.org/10.1136/thoraxjnl-2021-217362 .
doi: 10.1136/thoraxjnl-2021-217362 pubmed: 34088787
Koo S, Thomas HR, Daniels SD, Lynch RC, Fortier SM, Shea MM, Rearden P, Comolli JC, Baden LR, Marty FM. A breath fungal secondary metabolite signature to diagnose invasive aspergillosis. Clin Infect Dis. 2014;59:1733–40. https://doi.org/10.1093/cid/ciu725 .
doi: 10.1093/cid/ciu725 pubmed: 25342502 pmcid: 4311178
Kos R, Brinkman P, Neerincx A, Paff T, Gerritsen M, Lammers A, Kraneveld A, Heijerman H, Davies J, Janssens H, Majoor C, Weersink E, Sterk P, Haarman E, Bos L, Zee A. Targeted analysis of volatile organic compounds for detection of Pseudomonas aeruginosa in cystic fibrosis patients by exhaled breath analysis. J Cyst Fibros. 2020;19:52. https://doi.org/10.1016/j.jcf.2021.04.015 .
doi: 10.1016/j.jcf.2021.04.015
Gilchrist FJ, Belcher J, Jones AM, Smith D, Smyth AR, Southern KW, Spanel P, Webb AK, Lenney W. Exhaled breath hydrogen cyanide as a marker of early Pseudomonas aeruginosa infection in children with cystic fibrosis. ERJ Open Res. 2015;1:00044-2015-44–2015. https://doi.org/10.1183/23120541.00044-2015 .
doi: 10.1183/23120541.00044-2015
Pabary R, Huang J, Kumar S, Alton EWFW, Bush A, Hanna GB, Davie JC. Does mass spectrometric breath analysis detect Pseudomonas aeruginosa in cystic fibrosis? Eur Respir J. 2016;47:994–7. https://doi.org/10.1183/13993003.00944-2015 .
doi: 10.1183/13993003.00944-2015 pubmed: 26846826
Neerincx A, Geurts B, Loon J, Tiemes V, Jansen J, Harren F, Kluijtmans L, Merkus P, Cristescu S, Buydens L, Wevers R. Detection of Staphylococcus aureus in cystic fibrosis patients using breath VOC profiles. J Breath Res. 2016;10:046014. https://doi.org/10.1088/1752-7155/10/4/046014 .
doi: 10.1088/1752-7155/10/4/046014 pubmed: 27902490
Cole S, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon S, Eiglmeier K, Gas S, Barry C, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998;393:537–44. https://doi.org/10.1038/31159 .
doi: 10.1038/31159 pubmed: 9634230
Syhre M, Chambers S. The scent of Mycobacterium tuberculosis. Tuberculosis. 2008;88:317–23. https://doi.org/10.1016/j.tube.2008.01.002 .
doi: 10.1016/j.tube.2008.01.002 pubmed: 18296120
Chingin K, Liang J, Liu Y, Chen L, Wu X, Hu L, Ouyang Y. Rapid detection of Mycobacterium tuberculosis cultures by direct ambient corona discharge ionization mass spectrometry of volatile metabolites. RSC Adv. 2016;6:59749–52. https://doi.org/10.1039/C6RA12107A .
doi: 10.1039/C6RA12107A
McNerney R, Mallard K, Okolo P, Turner C. Production of volatile organic compounds by mycobacteria. FEMS Microbiol Lett. 2012;328:150–6. https://doi.org/10.1111/j.1574-6968.2011.02493.x .
doi: 10.1111/j.1574-6968.2011.02493.x pubmed: 22224870
Gouzy A, Poquet Y, Neyrolles O. Nitrogen metabolism in Mycobacterium tuberculosis physiology and virulence. Nat Rev Microbiol. 2014;12:729–37. https://doi.org/10.1038/nrmicro3349 .
doi: 10.1038/nrmicro3349 pubmed: 25244084
Leung CM, de Haan P, Ronaldson-Bouchard K, Kim G-A, Ko J, Rho HS, Chen Z, Habibovic P, Jeon NL, Takayama S, Shuler ML, Vunjak-Novakovic G, Frey O, Verpoorte E, Toh Y-C. A guide to the organ-on-a-chip. Nat Rev Methods Primer. 2022;2:1–29. https://doi.org/10.1038/s43586-022-00118-6 .
doi: 10.1038/s43586-022-00118-6
Gardner S, Hillis S, Heilmann K, Segre J, Grice E. The neuropathic diabetic foot ulcer microbiome Is associated with clinical factors. Diabetes. 2012;62:923–30. https://doi.org/10.2337/db12-0771 .
doi: 10.2337/db12-0771 pubmed: 23139351
Haalboom M, Gerritsen JW, Palen J van der (2019) Differentiation between infected and non-infected wounds using an electronic nose. Clin Microbiol Infect 25:1288.e1-1288.e6. https://doi.org/10.1016/j.cmi.2019.03.018
Brawner K, Morrow C, Smith P. Gastric microbiome and gastric cancer. Cancer J. 2014;20:211–6. https://doi.org/10.1097/PPO.0000000000000043 .
doi: 10.1097/PPO.0000000000000043 pubmed: 24855010 pmcid: 4149312
Zhang J, Tian Y, Luo Z, Qian C, Li W, Duan Y. Breath volatile organic compound analysis: an emerging method for gastric cancer detection. J Breath Res. 2021;15:044002. https://doi.org/10.1088/1752-7163/ac2cde .
doi: 10.1088/1752-7163/ac2cde
Zhan X, Duan J, Duan Y. Recent developments of proton-transfer reaction mass spectrometry (PTR-MS) and its applications in medical research. Mass Spectrom Rev. 2012;32:143–65. https://doi.org/10.1002/mas.21357 .
doi: 10.1002/mas.21357 pubmed: 23097015
Kumar S, Huang J, Abbassi-Ghadi N, Mackenzie HA, Veselkov KA, Hoare JM, Lovat LB, Španěl P, Smith D, Hanna GB. Mass spectrometric analysis of exhaled breath for the identification of volatile organic compound biomarkers in esophageal and gastric adenocarcinoma. Ann Surg. 2015;262:981–90. https://doi.org/10.1097/SLA.0000000000001101 .
doi: 10.1097/SLA.0000000000001101 pubmed: 25575255
Dospinescu V-M, Tiele A, Covington J. Sniffing Out Urinary Tract Infection—Diagnosis Based on Volatile Organic Compounds and Smell Profile. Biosensors. 2020;10:83. https://doi.org/10.3390/bios10080083 .
doi: 10.3390/bios10080083 pubmed: 32717983 pmcid: 7460005
Ibrahim W, Cordell RL, Wilde MJ, Richardson M, Carr L, Dasi ASD, Hargadon B, Free RC, Monks PS, Brightling CE, Greening NJ, Siddiqui S. Diagnosis of COVID-19 by exhaled breath analysis using gas chromatography–mass spectrometry. ERJ Open Res. 2021;7:00139–2021. https://doi.org/10.1183/23120541.00139-2021 .
doi: 10.1183/23120541.00139-2021 pubmed: 34235208 pmcid: 8255539
Berna AZ, Akaho EH, Harris RM, Congdon M, Korn E, Neher S, M’Farrej M, Burns J, Odom John AR. Reproducible breath metabolite changes in children with SARS-CoV-2 infection. ACS Infect Dis. 2021;7:2596–603. https://doi.org/10.1021/acsinfecdis.1c00248 .
doi: 10.1021/acsinfecdis.1c00248 pubmed: 34319698 pmcid: 8353987
Ratcliffe N, Wieczorek T, Drabińska N, Gould O, Osborne A, Lacy Costello B. A mechanistic study and review of volatile products from peroxidation of unsaturated fatty acids: an aid to understanding the origins of volatile organic compounds from the human body. J Breath Res. 2020;14:034001. https://doi.org/10.1088/1752-7163/ab7f9d .
doi: 10.1088/1752-7163/ab7f9d pubmed: 32163929
Fuchs P, Loeseken C, Schubert J, Miekisch W. Breath gas aldehydes as biomarkers of lung cancer. Int J Cancer. 2010;126:2663–70. https://doi.org/10.1002/ijc.24970 .
doi: 10.1002/ijc.24970 pubmed: 19839051
Aghdassi E, Allard JP. Breath alkanes as a marker of oxidative stress in different clinical conditions. Free Radic Biol Med. 2000;28:880–6. https://doi.org/10.1016/S0891-5849(00)00189-1 .
doi: 10.1016/S0891-5849(00)00189-1 pubmed: 10802218
Phillips M, Cataneo RN, Condos R, Ring Erickson GA, Greenberg J, La Bombardi V, Munawar MI, Tietje O. Volatile biomarkers of pulmonary tuberculosis in the breath. Tuberc Edinb Scotl. 2007;87:44–52. https://doi.org/10.1016/j.tube.2006.03.004 .
doi: 10.1016/j.tube.2006.03.004
Kunze N, Göpel J, Kuhns M, Jünger M, Quintel M, Perl T. Detection and validation of volatile metabolic patterns over different strains of two human pathogenic bacteria during their growth in a complex medium using multi-capillary column-ion mobility spectrometry (MCC-IMS). Appl Microbiol Biotechnol. 2013;97:3665–76. https://doi.org/10.1007/s00253-013-4762-8 .
doi: 10.1007/s00253-013-4762-8 pubmed: 23467822 pmcid: 3616217
Filipiak W, Sponring A, Baur M, Ager C, Filipiak A, Wiesenhofer H, Nagl M, Troppmair J, Amann A. Characterization of volatile metabolites taken up by or released from Streptococcus pneumoniae and Haemophilus influenzae by using GC-MS. Microbiology. 2012;158:3044–53. https://doi.org/10.1099/mic.0.062687-0 .
doi: 10.1099/mic.0.062687-0 pubmed: 23059976
Oort P, White I, Ahmed W, Johnson C, Bannard-Smith J, Felton T, Bos L, Goodacre R, Dark P, Fowler S. Detection and quantification of exhaled volatile organic compounds in mechanically ventilated patients – comparison of two sampling methods. The Analyst. 2021;146:222–31. https://doi.org/10.1039/C9AN01134J .
doi: 10.1039/C9AN01134J pubmed: 33103170
Drabińska N, Flynn C, Ratcliffe N, Belluomo I, Myridakis A, Gould O, Fois M, Smart A, Devine T, Costello BDL. A literature survey of all volatiles from healthy human breath and bodily fluids: the human volatilome. J Breath Res. 2021;15:034001. https://doi.org/10.1088/1752-7163/abf1d0 .
doi: 10.1088/1752-7163/abf1d0
Amann A, Al-Kateb H, Flynn C, Filipiak W, Khalid T, Osborne D, Ratcliffe NM. A review of the volatiles from the healthy human body. J Breath Res. 2014;8:014001. https://doi.org/10.1088/1752-7155/8/1/014001 .
doi: 10.1088/1752-7155/8/1/014001 pubmed: 24421258
Jiang R, Cudjoe E, Bojko B, Abaffy T, Pawliszyn J. A non-invasive method for in vivo skin volatile compounds sampling. Anal Chim Acta. 2013;804:111–9. https://doi.org/10.1016/j.aca.2013.09.056 .
doi: 10.1016/j.aca.2013.09.056 pubmed: 24267071
Duffy E, Morrin A. Endogenous and microbial volatile organic compounds in cutaneous health and disease. TrAC Trends Anal Chem. 2019;111:163–72. https://doi.org/10.1016/j.trac.2018.12.012 .
doi: 10.1016/j.trac.2018.12.012
Souza L, Alseekh S, Scossa F, Fernie A. Ultra-high-performance liquid chromatography high-resolution mass spectrometry variants for metabolomics research. Nat Methods. 2021;18:733–46. https://doi.org/10.1038/s41592-021-01116-4 .
doi: 10.1038/s41592-021-01116-4
Marshall AG, Hendrickson CL. High-resolution mass spectrometers. Annu Rev Anal Chem. 2008;1:579–99. https://doi.org/10.1146/annurev.anchem.1.031207.112945 .
doi: 10.1146/annurev.anchem.1.031207.112945
Hernández F, Fabregat-Safont D, Campos-Mañas M, Quintana JB. Efficient validation strategies in environmental analytical chemistry: A focus on organic micropollutants in water samples. Annu Rev Anal Chem. 2023;16:401–28. https://doi.org/10.1146/annurev-anchem-091222-112115 .
doi: 10.1146/annurev-anchem-091222-112115
Silva CL, Perestrelo R, Silva P, Tomás H, Câmara JS. Volatile metabolomic signature of human breast cancer cell lines. Sci Rep. 2017;7:43969. https://doi.org/10.1038/srep43969 .
doi: 10.1038/srep43969 pubmed: 28256598 pmcid: 5335623
Lavra L, Catini A, Ulivieri A, Capuano R, Baghernajad Salehi L, Sciacchitano S, Bartolazzi A, Nardis S, Paolesse R, Martinelli E, Di Natale C. Investigation of VOCs associated with different characteristics of breast cancer cells. Sci Rep. 2015;5:13246. https://doi.org/10.1038/srep13246 .
doi: 10.1038/srep13246 pubmed: 26304457 pmcid: 4548242
Zanella D, Henket M, Schleich F, Dejong T, Louis R, Focant J-F, Stefanuto P-H. Comparison of the effect of chemically and biologically induced inflammation on the volatile metabolite production of lung epithelial cells by GC×GC-TOFMS. The Analyst. 2020;145:5148–57. https://doi.org/10.1039/d0an00720j .
doi: 10.1039/d0an00720j pubmed: 32633741
Schivo M, Aksenov AA, Linderholm AL, McCartney MM, Simmons J, Harper RW, Davis CE. Volatile emanations from in vitro airway cells infected with human rhinovirus. J Breath Res. 2014;8:037110. https://doi.org/10.1088/1752-7155/8/3/037110 .
doi: 10.1088/1752-7155/8/3/037110 pubmed: 25189196 pmcid: 4182727
Ingber DE. Human organs-on-chips for disease modelling, drug development and personalized medicine. Nat Rev Genet. 2022;23:467–91. https://doi.org/10.1038/s41576-022-00466-9 .
doi: 10.1038/s41576-022-00466-9 pubmed: 35338360 pmcid: 8951665
Barkal LJ, Procknow CL, Álvarez-García YR, Niu M, Jiménez-Torres JA, Brockman-Schneider RA, Gern JE, Denlinger LC, Theberge AB, Keller NP, Berthier E, Beebe DJ. Microbial volatile communication in human organotypic lung models. Nat Commun. 2017;8:1770. https://doi.org/10.1038/s41467-017-01985-4 .
doi: 10.1038/s41467-017-01985-4 pubmed: 29176665 pmcid: 5701243

Auteurs

Shane Fitzgerald (S)

SFI Insight Centre for Data Analytics, School of Chemical Sciences, National Centre for Sensor Research, Dublin City University, Dublin, Ireland.

Linda Holland (L)

School of Biotechnology, Dublin City University, Dublin, Ireland.

Waqar Ahmed (W)

Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK.

Birgit Piechulla (B)

Institute of Biological Sciences, University of Rostock, Rostock, Germany.

Stephen J Fowler (SJ)

Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK.
Respiratory Medicine, Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester, UK.

Aoife Morrin (A)

SFI Insight Centre for Data Analytics, School of Chemical Sciences, National Centre for Sensor Research, Dublin City University, Dublin, Ireland. aoife.morrin@dcu.ie.

Classifications MeSH